Detailed information for compound 1115176

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 564.156 | Formula: C18H18I2N2O3
  • H donors: 3 H acceptors: 3 LogP: 4.38 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 2
  • SMILES: CC(/N=C/c1cc(I)cc(c1O)I)CNC(=O)c1ccc(cc1O)C
  • InChi: 1S/C18H18I2N2O3/c1-10-3-4-14(16(23)5-10)18(25)22-8-11(2)21-9-12-6-13(19)7-15(20)17(12)24/h3-7,9,11,23-24H,8H2,1-2H3,(H,22,25)/b21-9+
  • InChiKey: WOXQRZVBSDKROY-ZVBGSRNCSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Escherichia coli 3-oxoacyl-[acyl-carrier-protein] synthase III Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Plasmodium knowlesi beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans beta-ketoacyl synthase-like protein Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Neospora caninum 3-oxoacyl-(acyl-carrier-protein) synthase III family protein, putative Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) Get druggable targets OG5_129509 All targets in OG5_129509
Chlamydia trachomatis oxoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium berghei apicoplast beta-ketoacyl-acyl carrier protein synthase III precursor, putative Get druggable targets OG5_129509 All targets in OG5_129509
Plasmodium falciparum beta-ketoacyl-ACP synthase III Get druggable targets OG5_129509 All targets in OG5_129509
Mycobacterium ulcerans 3-oxoacyl-ACP synthase Get druggable targets OG5_129509 All targets in OG5_129509

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Conserved hypothetical protein 3-oxoacyl-[acyl-carrier-protein] synthase III 317 aa 265 aa 26.0 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1014 1
Mycobacterium tuberculosis Probable esterase LipL 0.0038 0.0704 0.0704
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 1 1
Mycobacterium ulcerans hypothetical protein 0.0038 0.0704 0.0704
Brugia malayi glutaminase DH11.1 0.0187 0.472 1
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0983 0.0694
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 0.0983 1
Loa Loa (eye worm) hypothetical protein 0.0016 0.0111 0.0234
Mycobacterium tuberculosis Possible conserved lipoprotein LpqK 0.0038 0.0704 0.0704
Loa Loa (eye worm) hypothetical protein 0.0016 0.0111 0.0234
Loa Loa (eye worm) hypothetical protein 0.0016 0.0111 0.0234
Brugia malayi Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative 0.0038 0.0704 0.1287
Trypanosoma cruzi hypothetical protein, conserved 0.0038 0.0704 1
Onchocerca volvulus 0.0038 0.0704 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0983 0.0694
Mycobacterium tuberculosis Conserved protein 0.0038 0.0704 0.0704
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1014 1
Mycobacterium ulcerans long-chain-fatty-acid--CoA ligase 0.0016 0.0111 0.0111
Loa Loa (eye worm) transcription factor SMAD2 0.0132 0.3219 0.6821
Loa Loa (eye worm) glutaminase 0.0187 0.472 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0027 0.039 0.039
Brugia malayi beta-lactamase family protein 0.0038 0.0704 0.1287
Onchocerca volvulus 0.0038 0.0704 1
Mycobacterium leprae conserved hypothetical protein 0.0038 0.0704 1
Brugia malayi hypothetical protein 0.0027 0.039 0.0607
Toxoplasma gondii ABC1 family protein 0.0038 0.0704 1
Mycobacterium ulcerans glutaminase 0.0187 0.472 0.472
Mycobacterium ulcerans beta-ketoacyl synthase-like protein 0.0383 1 1
Plasmodium vivax hypothetical protein, conserved 0.0038 0.0704 0.0704
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0049 0.0983 0.2082
Mycobacterium tuberculosis Conserved protein 0.0038 0.0704 0.0704
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 0.0983 1
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 0.0983 1
Schistosoma mansoni glutaminase 0.0187 0.472 1
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1014 1
Mycobacterium tuberculosis 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) 0.0383 1 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0027 0.039 0.039
Loa Loa (eye worm) glutaminase 2 0.0187 0.472 1
Plasmodium vivax beta-ketoacyl-acyl carrier protein synthase III precursor, putative 0.0383 1 1
Brugia malayi beta-lactamase 0.0038 0.0704 0.1287
Brugia malayi beta-lactamase family protein 0.0038 0.0704 0.1287
Mycobacterium tuberculosis Probable conserved lipoprotein 0.0038 0.0704 0.0704
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Plasmodium falciparum beta-ketoacyl-ACP synthase III 0.0383 1 1
Leishmania major hypothetical protein, conserved 0.0027 0.039 0.4716
Mycobacterium ulcerans acyl-CoA synthetase 0.0016 0.0111 0.0111
Loa Loa (eye worm) beta-LACTamase domain containing family member 0.0038 0.0704 0.1491
Trypanosoma cruzi hypothetical protein, conserved 0.0038 0.0704 1
Loa Loa (eye worm) MH2 domain-containing protein 0.0132 0.3219 0.6821
Brugia malayi MH2 domain containing protein 0.0132 0.3219 0.6744
Mycobacterium tuberculosis Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) 0.0016 0.0111 0.0111
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0049 0.0983 0.1892
Mycobacterium tuberculosis Probable hydrolase 0.0038 0.0704 0.0704
Mycobacterium ulcerans acyl-CoA synthetase 0.0016 0.0111 0.0111
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1014 1
Mycobacterium ulcerans long-chain-fatty-acid-CoA ligase 0.0016 0.0111 0.0111
Loa Loa (eye worm) beta-lactamase 0.0038 0.0704 0.1491
Mycobacterium tuberculosis Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) 0.0016 0.0111 0.0111
Mycobacterium tuberculosis Probable lipase LipD 0.0038 0.0704 0.0704
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Mycobacterium ulcerans esterase/lipase LipP 0.0038 0.0704 0.0704
Mycobacterium ulcerans fatty-acid-CoA ligase 0.0016 0.0111 0.0111
Mycobacterium ulcerans 3-oxoacyl-ACP synthase 0.0383 1 1
Leishmania major hypothetical protein, conserved 0.0038 0.0704 1
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Mycobacterium tuberculosis Conserved protein 0.0038 0.0704 0.0704
Entamoeba histolytica fatty acid elongase, putative 0.005 0.1014 1
Plasmodium vivax ataxin-2 like protein, putative 0.0027 0.039 0.039
Mycobacterium ulcerans lipase LipD 0.0038 0.0704 0.0704
Mycobacterium tuberculosis Probable esterase/lipase LipP 0.0038 0.0704 0.0704
Mycobacterium ulcerans hypothetical protein 0.0016 0.0111 0.0111
Mycobacterium ulcerans long-chain fatty-acid CoA ligase 0.0016 0.0111 0.0111
Brugia malayi hypothetical protein 0.0017 0.0136 0.0055
Mycobacterium ulcerans beta-lactamase 0.0038 0.0704 0.0704
Trypanosoma brucei hypothetical protein, conserved 0.0038 0.0704 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0983 0.0694
Onchocerca volvulus 0.0038 0.0704 1
Mycobacterium ulcerans acyl-CoA synthetase 0.0016 0.0111 0.0111
Trichomonas vaginalis glutaminase, putative 0.0187 0.472 1
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0038 0.0704 0.0704
Wolbachia endosymbiont of Brugia malayi 3-oxoacyl-ACP synthase 0.0383 1 0.5
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 0.0983 1
Mycobacterium tuberculosis Possible penicillin-binding protein 0.0244 0.6259 0.6259
Loa Loa (eye worm) hypothetical protein 0.0038 0.0704 0.1491
Mycobacterium leprae Probable lipase LipE 0.0038 0.0704 1
Loa Loa (eye worm) hypothetical protein 0.0027 0.039 0.0827
Mycobacterium tuberculosis Probable lipase LipE 0.0038 0.0704 0.0704

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 14.95 ug ml-1 Inhibition of Escherichia coli KAS3 after 1 min assessed as incorporation of 3H signal in the final product by liquid scintillation counter ChEMBL. 20304657

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.